FIGURE 1.
Flow diagram of randomized patients in the JCOG0908 study comparing R‐CHOP‐14 (arm A) with R‐CHOP‐14/CHASER (arm B). AE, adverse event; ASCT, autologous stem‐cell transplantation; CHASER, cyclophosphamide, cytarabine, etoposide, dexamethasone, and rituximab; HDCT, high‐dose chemotherapy; Pts, patients; R‐CHOP‐14, rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone with 14‐d interval; RT, radiation therapy